cethromycin

Data on the Company's lead product, Restanza (TM) (cethromycin), its novel once-daily oral antibiotic, will be presented showing the drug's efficacy against 30 strains of

RedOrbit News - Technology 2010

Pilot phenergan aciphex phentermine actos actos ranitidine of romper hydrochloride for the mankind of tetracosanoic housewives in cethromycin survivors.

Wii-volution 2010

The report highlights Restanza™ cethromycin as a promising late-stage antibacterial treatment for life-threatening pathogens.

Dawson James Initiates Research Coverage of Advanced Life Sciences - Yahoo! Finance 2010

The milestone was triggered upon submission of the cethromycin NDA to the FDA, which occurred on September 30, 2008.

GuruFocus Updates - 2009

The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any other indication.

unknown title 2009

"We are eagerly preparing for this upcoming Advisory Committee meeting and we are looking forward to the opportunity to present not only the clinical safety and efficacy of our drug, but also the medical need for a product like cethromycin," said Dr. Michael Flavin, Chairman and CEO of Advanced Life Sciences.

unknown title 2009

At the meeting, the Committee will discuss new drug application (NDA) 22-398, cethromycin oral tablets, sponsored by Advanced Life Sciences, for the proposed indication of outpatient treatment of adults with mild to moderate community-acquired pneumonia (CAP).

unknown title 2009

As previously mentioned, included in the prior year amount is a $10.0 million milestone expense incurred under our license agreement for cethromycin with Abbott.

GuruFocus Updates - 2009

In November 2008, the FDA filed the Company's NDA for cethromycin and established a target Prescription Drug User Fee Act (PDUFA) action date for the cethromycin NDA of July 31, 2009.

unknown title 2009

In addition to its utility in CAP, cethromycin is also being investigated as a broad spectrum biodefense countermeasure to combat agents of bioterror including anthrax, tularemia, plague and melioidosis.

unknown title 2009